IL6 and breast cancer: Magidey-Klein et al. used paired breast cancer or melanoma cell lines, one with a high frequency of metastasis (met-high) and one with a low frequency of metastasis (met-low), to study the role of IL-6 in HPSC differentiation, metastasis, and its involvement in the generation of the PMN.